Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 180

1.

Evaluation of transdermal application of glipizide in a pluronic lecithin gel to healthy cats.

Bennett N, Papich MG, Hoenig M, Fettman MJ, Lappin MR.

Am J Vet Res. 2005 Apr;66(4):581-8.

PMID:
15900936
2.

Effect of glipizide on serum insulin and glucose concentrations in healthy cats.

Miller AB, Nelson RW, Kirk CA, Neal L, Feldman EC.

Res Vet Sci. 1992 Mar;52(2):177-81.

PMID:
1585076
3.

The influence of multiple dosing and age on the pharmacokinetics and pharmacodynamics of glipizide in patients with type II diabetes mellitus.

Jaber LA, Ducharme MP, Edwards DJ, Slaughter RL, Grunberger G.

Pharmacotherapy. 1996 Sep-Oct;16(5):760-8.

PMID:
8888072
4.

Comparison of pharmacodynamic variables following oral versus transdermal administration of atenolol to healthy cats.

Macgregor JM, Rush JE, Rozanski EA, Boothe DM, Belmonte AA, Freeman LM.

Am J Vet Res. 2008 Jan;69(1):39-44. doi: 10.2460/ajvr.69.1.39.

PMID:
18167085
5.

Pharmacokinetics and pharmacodynamics of glipizide after once-daily and divided doses.

Kradjan WA, Takeuchi KY, Opheim KE, Wood FC Jr.

Pharmacotherapy. 1995 Jul-Aug;15(4):465-71.

PMID:
7479199
6.

Comparison of serum dexamethasone concentrations in cats after oral or transdermal administration using pluronic lecithin organogel (PLO): a pilot study.

Willis-Goulet HS, Schmidt BA, Nicklin CF, Marsella R, Kunkle GA, Tebbett IR.

Vet Dermatol. 2003 Apr;14(2):83-9.

PMID:
12662265
7.

Effects of rifampin on the pharmacokinetics and pharmacodynamics of glyburide and glipizide.

Niemi M, Backman JT, Neuvonen M, Neuvonen PJ, Kivistö KT.

Clin Pharmacol Ther. 2001 Jun;69(6):400-6.

PMID:
11406737
8.

Pharmacological evaluation of membrane-moderated transdermal system of glipizide.

Mutalik S, Udupa N.

Clin Exp Pharmacol Physiol. 2006 Jan-Feb;33(1-2):17-26.

PMID:
16445694
9.

Effect of an orally administered sulfonylurea, glipizide, for treatment of diabetes mellitus in cats.

Nelson RW, Feldman EC, Ford SL, Roemer OP.

J Am Vet Med Assoc. 1993 Sep 15;203(6):821-7.

PMID:
8226235
10.

Bioavailability of transdermal methimazole in a pluronic lecithin organogel (PLO) in healthy cats.

Hoffman SB, Yoder AR, Trepanier LA.

J Vet Pharmacol Ther. 2002 Jun;25(3):189-93.

PMID:
12081614
11.

The pharmacokinetics of methimazole in a novel lipophilic formulation administered transdermally to healthy cats.

Hill KE, Gieseg MA, Bridges J, Chambers JP.

N Z Vet J. 2014 Jul;62(4):208-13. doi: 10.1080/00480169.2013.875990. Epub 2014 Feb 28.

PMID:
24350893
12.

Pharmacokinetics of the insulin-sensitizing agent troglitazone in cats.

Michels GM, Boudinot FD, Ferguson DC, Hoenig M.

Am J Vet Res. 2000 Jul;61(7):775-8.

PMID:
10895899
13.

Comparison of pharmacokinetics of fentanyl after intravenous and transdermal administration in cats.

Lee DD, Papich MG, Hardie EM.

Am J Vet Res. 2000 Jun;61(6):672-7.

PMID:
10850844
14.

Omeprazole absorption from a compounded transdermal formulation in healthy volunteers.

Haas CE, Lin L, Cloen D, Kufel T, Moon R, Frerichs V.

J Am Pharm Assoc (2003). 2005 Jul-Aug;45(4):473-8.

PMID:
16128503
15.

Passive and iontophoretic permeation of glipizide gel: an in vitro and in vivo study.

Ghosh B, Jain A, Ashok P, Patel B, Tarafdar K.

Curr Drug Deliv. 2009 Oct;6(5):444-50.

PMID:
19751199
16.

Intensive 50-week evaluation of glipizide administration in 50 cats with previously untreated diabetes mellitus.

Feldman EC, Nelson RW, Feldman MS.

J Am Vet Med Assoc. 1997 Mar 15;210(6):772-7.

PMID:
9074678
17.

Plasma fentanyl concentrations and analgesic effects during full or partial exposure to transdermal fentanyl patches in cats.

Davidson CD, Pettifer GR, Henry JD Jr.

J Am Vet Med Assoc. 2004 Mar 1;224(5):700-5.

PMID:
15002807
18.

Effect of hormone therapy on the enteroinsular axis.

Sztefko K, Rogatko I, Milewicz T, Józef K, Tomasik PJ, Szafran Z.

Menopause. 2005 Sep-Oct;12(5):630-638.

PMID:
16145319
19.

Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.

Bergman AJ, Stevens C, Zhou Y, Yi B, Laethem M, De Smet M, Snyder K, Hilliard D, Tanaka W, Zeng W, Tanen M, Wang AQ, Chen L, Winchell G, Davies MJ, Ramael S, Wagner JA, Herman GA.

Clin Ther. 2006 Jan;28(1):55-72.

PMID:
16490580
20.

Pharmacokinetics and pharmacodynamics of extended-release glipizide GITS compared with immediate-release glipizide in patients with type II diabetes mellitus.

Chung M, Kourides I, Canovatchel W, Sutfin T, Messig M, Chaiken RL.

J Clin Pharmacol. 2002 Jun;42(6):651-7.

PMID:
12043953

Supplemental Content

Support Center